Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Filters applied: . Clear all
Page 1
Exploration of uncertainty of PRx time trends.
Beqiri E, Placek MM, Chu KH, Donnelly J, Cucciolini G, Motroni V, Smith CA, Czosnyka M, Hutchinson P, Smielewski P. Beqiri E, et al. Among authors: chu kh. Brain Spine. 2024 Mar 31;4:102795. doi: 10.1016/j.bas.2024.102795. eCollection 2024. Brain Spine. 2024. PMID: 38601774 Free PMC article.
However, a recent Delphi consensus of clinicians concluded that consensus could not be reached on the accuracy, reliability, and validation of any current CA assessment method. RESEARCH QUESTION: We aimed to quantify the short-term uncertainty of PRx time-trends and to rel …
However, a recent Delphi consensus of clinicians concluded that consensus could not be reached on the accuracy, reliability, and validation …
Excellent thermomagnetic power generation for harvesting waste heat via a second-order ferromagnetic transition.
Chen H, Liu X, Liu Y, Xie L, Yu Z, Qiao K, Liu M, Hu F, Shen B, Ramanujan RV, Chu K, Zhang H. Chen H, et al. Among authors: chu k. Mater Horiz. 2024 Apr 8. doi: 10.1039/d3mh02225k. Online ahead of print. Mater Horiz. 2024. PMID: 38587002
In addition, Ni(2)Mn(1.4)In(0.6) with SOMT also shows some advantages that first-order magnetic transition (FOMT) materials do not have, such as zero hysteresis and a long-term service life. In contrast to the short lifetime of a few minutes for the materials with FOMT, Ni …
In addition, Ni(2)Mn(1.4)In(0.6) with SOMT also shows some advantages that first-order magnetic transition (FOMT) materials do not have, suc …
Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure.
Lee CG, Ciarleglio A, Edelstein SL, Crandall JP, Dabelea D, Goldberg RB, Kahn SE, Knowler WC, Ma MT, White NH, Herman WH; Diabetes Prevention Program Research Group. Lee CG, et al. Diabetes Care. 2024 May 1;47(5):810-817. doi: 10.2337/dc23-2009. Diabetes Care. 2024. PMID: 38502874 Clinical Trial.
CONCLUSIONS: The likelihood of DSPN was similar across DPP treatment groups but higher for those with diabetes, longer diabetes duration, and higher cumulative glycemic exposure. ILS may have long-term benefits on DSPN for older adults....
CONCLUSIONS: The likelihood of DSPN was similar across DPP treatment groups but higher for those with diabetes, longer diabetes duration, an …
Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial.
Rasouli N, Younes N, Ghosh A, Albu J, Cohen RM, DeFronzo RA, Diaz E, Sayyed Kassem L, Luchsinger JA, McGill JB, Sivitz WI, Tamborlane WV, Utzschneider KM, Kahn SE; GRADE Research Group. Rasouli N, et al. Diabetes Care. 2024 Apr 1;47(4):580-588. doi: 10.2337/dc23-1070. Diabetes Care. 2024. PMID: 38211595 Clinical Trial.
OBJECTIVE: To compare the long-term effects of glucose-lowering medications (insulin glargine U-100, glimepiride, liraglutide, and sitagliptin) when added to metformin on insulin sensitivity and beta-cell function. ...After adjustment for HOMA2-%S to obtain an estimate of …
OBJECTIVE: To compare the long-term effects of glucose-lowering medications (insulin glargine U-100, glimepiride, liraglutide, and si …
Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy.
Utzschneider KM, Younes N, Butera NM, Balasubramanyam A, Bergenstal RM, Barzilay J, DeSouza C, DeFronzo RA, Elasy T, Krakoff J, Kahn SE, Rasouli N, Valencia WM, Sivitz WI; GRADE Research Group. Utzschneider KM, et al. Diabetes Care. 2024 Apr 1;47(4):571-579. doi: 10.2337/dc23-1059. Diabetes Care. 2024. PMID: 38190619 Clinical Trial.
CONCLUSIONS: Insulin sensitivity and beta-cell function affected treatment outcomes irrespective of drug assignment, with greater impact in the sitagliptin group on initial (short-term) HbA1c response in comparison with the glimepiride and liraglutide groups....
CONCLUSIONS: Insulin sensitivity and beta-cell function affected treatment outcomes irrespective of drug assignment, with greater impact in …
Pd1Cu Single-Atom Alloys for High-Current-Density and Durable NO-to-NH3 Electroreduction.
Chen K, Xiang J, Guo Y, Liu X, Li X, Chu K. Chen K, et al. Among authors: chu k. Nano Lett. 2024 Jan 17;24(2):541-548. doi: 10.1021/acs.nanolett.3c02259. Epub 2024 Jan 7. Nano Lett. 2024. PMID: 38185876
Consequently, the flow cell assembled with Pd(1)Cu exhibits an unprecedented NH(3) yield rate of 1341.3 mumol h(-1) cm(-2) and NH(3)-Faradaic efficiency of 85.5% at an industrial-level current density of 210.3 mA cm(-2), together with an excellent long-term durability for …
Consequently, the flow cell assembled with Pd(1)Cu exhibits an unprecedented NH(3) yield rate of 1341.3 mumol h(-1) cm(-2) and NH(3)-Faradai …
Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial.
Cuzick J, Chu K, Keevil B, Brentnall AR, Howell A, Zdenkowski N, Bonanni B, Loibl S, Holli K, Evans DG, Cummings S, Dowsett M. Cuzick J, et al. Among authors: chu k. Lancet Oncol. 2024 Jan;25(1):108-116. doi: 10.1016/S1470-2045(23)00578-8. Epub 2023 Dec 6. Lancet Oncol. 2024. PMID: 38070530 Free article. Clinical Trial.
The trial was registered with ISRCTN (number ISRCTN31488319) and completed recruitment on Jan 31, 2012, but long-term follow-up is ongoing. FINDINGS: 3864 women were recruited into the trial between Feb 2, 2003, and Jan 31, 2012, and randomly assigned to receive anastrozol …
The trial was registered with ISRCTN (number ISRCTN31488319) and completed recruitment on Jan 31, 2012, but long-term follow-up is on …
Remediation of PFAS-impacted soils using magnetic activated carbon (MAC) and hydrothermal alkaline treatment (HALT).
Shih CH, Kim J, Yang SH, Soker O, Strathmann TJ, Chu KH. Shih CH, et al. Among authors: chu kh. Sci Total Environ. 2024 Feb 20;912:168931. doi: 10.1016/j.scitotenv.2023.168931. Epub 2023 Dec 1. Sci Total Environ. 2024. PMID: 38042197
Per- and polyfluoroalkyl substances (PFAS) are a group of synthetic pollutants that are bioaccumulative, toxic, and persistent. One long-term source for PFAS release is PFAS-contaminated soil. Addition of activated carbon (AC) to soil has shown the potential to immobilize …
Per- and polyfluoroalkyl substances (PFAS) are a group of synthetic pollutants that are bioaccumulative, toxic, and persistent. One long- …
Ampere-Level Nitrate Electroreduction to Ammonia over Monodispersed Bi-Doped FeS2.
Zhang G, Wang G, Wan Y, Liu X, Chu K. Zhang G, et al. Among authors: chu k. ACS Nano. 2023 Nov 14;17(21):21328-21336. doi: 10.1021/acsnano.3c05946. Epub 2023 Oct 23. ACS Nano. 2023. PMID: 37870919
Consequently, the specially designed flow cell equipped with Bi-FeS(2) exhibits a high NH(3) yield rate of 83.7 mg h(-1) cm(-2) with a near-100% NO(3)(-)-to-NH(3) Faradaic efficiency at an ampere-level current density of 1023.2 mA cm(-2), together with an excellent long-term …
Consequently, the specially designed flow cell equipped with Bi-FeS(2) exhibits a high NH(3) yield rate of 83.7 mg h(-1) cm(-2) with a near- …
Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial.
Hu J, Liu Y, Liu S, Shu Q, Yang X, Chu K, Qiao Y, Hu Y, Wang K, Pan H. Hu J, et al. Among authors: chu k. Front Immunol. 2023 Sep 18;14:1241153. doi: 10.3389/fimmu.2023.1241153. eCollection 2023. Front Immunol. 2023. PMID: 37799724 Free PMC article. Clinical Trial.
CLINICAL TRIAL REGISTRATION: https://classic.clinicaltrials.gov/ct2/show/NCT05381350?term=NCT05381350&draw=2&rank=1, identifier NCT05381350....
CLINICAL TRIAL REGISTRATION: https://classic.clinicaltrials.gov/ct2/show/NCT05381350?term=NCT05381350&draw=2&rank=1, identifi …
179 results